DexCom (NASDAQ:DXCM) Given New $153.00 Price Target at Rober

DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Robert W. Baird from $145.00 to $153.00 in a research note issued to investors on Friday, FlyOnTheWall reports. DXCM has been the subject of a number of other research reports. Citigroup raised their target price on shares of DexCom from $146.00 to $150.00 in […]

Related Keywords

United States , Robertw Baird , Steven Robert Pacelli , Jeremem Sylvain , Dexcom Inc , First Horizon Advisors Inc , Barclays , Dexcom Company Profile , Citigroup , Fulton Bank , Nasdaq , Brown Brothers Harriman Co , Centaurus Financial Inc , Covenant Partners , Free Report , Moderate Buy , Get Free Report , Director Steven Robert Pacelli , Horizon Advisors , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,